ADIPOQ and metabolic disease: Overall, obesity-induced FGF21 resistance induces various metabolic diseases by impairing the direct effects of FGF21 and the indirect effects mediated by adiponectin or other factors leading to metabolic disorders, which might account for the explanation of the elevated FGF21 level in metabolic diseases.